<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2023//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_230101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">34099552</PMID><DateCompleted><Year>2021</Year><Month>12</Month><Day>03</Day></DateCompleted><DateRevised><Year>2023</Year><Month>09</Month><Day>20</Day></DateRevised><Article PubModel="Print"><Journal><ISSN IssnType="Electronic">1091-6490</ISSN><JournalIssue CitedMedium="Internet"><Volume>118</Volume><Issue>24</Issue><PubDate><Year>2021</Year><Month>Jun</Month><Day>15</Day></PubDate></JournalIssue><Title>Proceedings of the National Academy of Sciences of the United States of America</Title><ISOAbbreviation>Proc Natl Acad Sci U S A</ISOAbbreviation></Journal><ArticleTitle>ALS- and FTD-associated missense mutations in TBK1 differentially disrupt mitophagy.</ArticleTitle><ELocationID EIdType="pii" ValidYN="Y">e2025053118</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.1073/pnas.2025053118</ELocationID><Abstract><AbstractText>TANK-binding kinase 1 (TBK1) is a multifunctional kinase with an essential role in mitophagy, the selective clearance of damaged mitochondria. More than 90 distinct mutations in TBK1 are linked to amyotrophic lateral sclerosis (ALS) and fronto-temporal dementia, including missense mutations that disrupt the abilities of TBK1 to dimerize, associate with the mitophagy receptor optineurin (OPTN), autoactivate, or catalyze phosphorylation. We investigated how ALS-associated mutations in TBK1 affect Parkin-dependent mitophagy using imaging to dissect the molecular mechanisms involved in clearing damaged mitochondria. Some mutations cause severe dysregulation of the pathway, while others induce limited disruption. Mutations that abolish either TBK1 dimerization or kinase activity were insufficient to fully inhibit mitophagy, while mutations that reduced both dimerization and kinase activity were more disruptive. Ultimately, both TBK1 recruitment and OPTN phosphorylation at S177 are necessary for engulfment of damaged mitochondra by autophagosomal membranes. Surprisingly, we find that ULK1 activity contributes to the phosphorylation of OPTN in the presence of either wild-type or kinase-inactive TBK1. In primary neurons, TBK1 mutants induce mitochondrial stress under basal conditions; network stress is exacerbated with further mitochondrial insult. Our study further refines the model for TBK1 function in mitophagy, demonstrating that some ALS-linked mutations likely contribute to disease pathogenesis by inducing mitochondrial stress or inhibiting mitophagic flux. Other TBK1 mutations exhibited much less impact on mitophagy in our assays, suggesting that cell-type-specific effects, cumulative damage, or alternative TBK1-dependent pathways such as innate immunity and inflammation also factor into the development of ALS in affected individuals.</AbstractText><CopyrightInformation>Copyright &#xa9; 2021 the Author(s). Published by PNAS.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Harding</LastName><ForeName>Olivia</ForeName><Initials>O</Initials><Identifier Source="ORCID">0000-0002-0719-2901</Identifier><AffiliationInfo><Affiliation>Department of Physiology, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA 19104.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Aligning Science Across Parkinson's Collaborative Research Network, Chevy Chase, MD 20815.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Evans</LastName><ForeName>Chantell S</ForeName><Initials>CS</Initials><Identifier Source="ORCID">0000-0001-9401-8604</Identifier><AffiliationInfo><Affiliation>Department of Physiology, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA 19104.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Aligning Science Across Parkinson's Collaborative Research Network, Chevy Chase, MD 20815.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ye</LastName><ForeName>Junqiang</ForeName><Initials>J</Initials><Identifier Source="ORCID">0000-0002-4529-0713</Identifier><AffiliationInfo><Affiliation>Department of Biochemistry and Molecular Biophysics, Vagelos College of Physicians and Surgeons, Columbia University, New York, NY 10032.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Zuckerman Mind Brain and Behavior Institute, Columbia University, New York, NY 10027.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Cheung</LastName><ForeName>Jonah</ForeName><Initials>J</Initials><Identifier Source="ORCID">0000-0002-1014-0707</Identifier><AffiliationInfo><Affiliation>Special Projects Group, New York Structural Biology Center, New York, NY 10027.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Maniatis</LastName><ForeName>Tom</ForeName><Initials>T</Initials><Identifier Source="ORCID">0000-0002-2722-8633</Identifier><AffiliationInfo><Affiliation>Department of Biochemistry and Molecular Biophysics, Vagelos College of Physicians and Surgeons, Columbia University, New York, NY 10032.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Zuckerman Mind Brain and Behavior Institute, Columbia University, New York, NY 10027.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>New York Genome Center, New York, NY 10013.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Holzbaur</LastName><ForeName>Erika L F</ForeName><Initials>ELF</Initials><Identifier Source="ORCID">0000-0001-5389-4114</Identifier><AffiliationInfo><Affiliation>Department of Physiology, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA 19104; holzbaur@pennmedicine.upenn.edu.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Aligning Science Across Parkinson's Collaborative Research Network, Chevy Chase, MD 20815.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>R01 NS060698</GrantID><Acronym>NS</Acronym><Agency>NINDS NIH HHS</Agency><Country>United States</Country></Grant><Grant><Acronym>HHMI</Acronym><Agency>Howard Hughes Medical Institute</Agency><Country>United States</Country></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D052061">Research Support, N.I.H., Extramural</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType></PublicationTypeList></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>Proc Natl Acad Sci U S A</MedlineTA><NlmUniqueID>7505876</NlmUniqueID><ISSNLinking>0027-8424</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D018797">Cell Cycle Proteins</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D047908">Intracellular Signaling Peptides and Proteins</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="C477012">MAP1LC3A protein, human</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D026901">Membrane Transport Proteins</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D008869">Microtubule-Associated Proteins</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D050505">Mutant Proteins</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="C409460">OPTN protein, human</NameOfSubstance></Chemical><Chemical><RegistryNumber>EC 2.7.11.1</RegistryNumber><NameOfSubstance UI="D000071189">Autophagy-Related Protein-1 Homolog</NameOfSubstance></Chemical><Chemical><RegistryNumber>EC 2.7.11.1</RegistryNumber><NameOfSubstance UI="D017346">Protein Serine-Threonine Kinases</NameOfSubstance></Chemical><Chemical><RegistryNumber>EC 2.7.11.1</RegistryNumber><NameOfSubstance UI="C403191">TBK1 protein, human</NameOfSubstance></Chemical><Chemical><RegistryNumber>EC 2.7.11.1</RegistryNumber><NameOfSubstance UI="C484754">ULK1 protein, human</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000690" MajorTopicYN="N">Amyotrophic Lateral Sclerosis</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="Y">genetics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000071189" MajorTopicYN="N">Autophagy-Related Protein-1 Homolog</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D018797" MajorTopicYN="N">Cell Cycle Proteins</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D057180" MajorTopicYN="N">Frontotemporal Dementia</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="Y">genetics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D020022" MajorTopicYN="N">Genetic Predisposition to Disease</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006367" MajorTopicYN="N">HeLa Cells</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D047908" MajorTopicYN="N">Intracellular Signaling Peptides and Proteins</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D007700" MajorTopicYN="N">Kinetics</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D026901" MajorTopicYN="N">Membrane Transport Proteins</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D008869" MajorTopicYN="N">Microtubule-Associated Proteins</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D008928" MajorTopicYN="N">Mitochondria</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName><QualifierName UI="Q000473" MajorTopicYN="N">pathology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D063306" MajorTopicYN="N">Mitophagy</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="Y">genetics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D050505" MajorTopicYN="N">Mutant Proteins</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D020125" MajorTopicYN="N">Mutation, Missense</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="Y">genetics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D018384" MajorTopicYN="N">Oxidative Stress</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D010766" MajorTopicYN="N">Phosphorylation</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000072417" MajorTopicYN="N">Protein Domains</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D055503" MajorTopicYN="N">Protein Multimerization</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D017346" MajorTopicYN="N">Protein Serine-Threonine Kinases</DescriptorName><QualifierName UI="Q000737" MajorTopicYN="N">chemistry</QualifierName><QualifierName UI="Q000235" MajorTopicYN="Y">genetics</QualifierName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">OPTN</Keyword><Keyword MajorTopicYN="N">Parkin</Keyword><Keyword MajorTopicYN="N">TBK1</Keyword><Keyword MajorTopicYN="N">mitophagy</Keyword><Keyword MajorTopicYN="N">neurodegeneration</Keyword></KeywordList><CoiStatement>The authors declare no competing interest.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="entrez"><Year>2021</Year><Month>6</Month><Day>8</Day><Hour>5</Hour><Minute>58</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2021</Year><Month>6</Month><Day>9</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2021</Year><Month>12</Month><Day>15</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">34099552</ArticleId><ArticleId IdType="pmc">PMC8214690</ArticleId><ArticleId IdType="doi">10.1073/pnas.2025053118</ArticleId><ArticleId IdType="pii">2025053118</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Cirulli E. T., et al. ., Exome sequencing in amyotrophic lateral sclerosis identifies risk genes and pathways. Science 347, 1436&#x2013;1441 (2015).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4437632</ArticleId><ArticleId IdType="pubmed">25700176</ArticleId></ArticleIdList></Reference><Reference><Citation>Brenner D., et al. ., Hot-spot KIF5A mutations cause familial ALS. Brain 141, 688&#x2013;697 (2018).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5837483</ArticleId><ArticleId IdType="pubmed">29342275</ArticleId></ArticleIdList></Reference><Reference><Citation>Freischmidt A., et al. ., Haploinsufficiency of TBK1 causes familial ALS and fronto-temporal dementia. Nat. Neurosci. 18, 631&#x2013;636 (2015).</Citation><ArticleIdList><ArticleId IdType="pubmed">25803835</ArticleId></ArticleIdList></Reference><Reference><Citation>Freischmidt A., M&#xfc;ller K., Ludolph A. C., Weishaupt J. H., Andersen P. M., Association of mutations in TBK1 with sporadic and familial amyotrophic lateral sclerosis and frontotemporal dementia. JAMA Neurol. 74, 110&#x2013;113 (2017).</Citation><ArticleIdList><ArticleId IdType="pubmed">27892983</ArticleId></ArticleIdList></Reference><Reference><Citation>van Rheenen W.et al. .; PARALS Registry; SLALOM Group; SLAP Registry; FALS Sequencing Consortium; SLAGEN Consortium; NNIPPS Study Group , Genome-wide association analyses identify new risk variants and the genetic architecture of amyotrophic lateral sclerosis. Nat. Genet. 48, 1043&#x2013;1048 (2016).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5556360</ArticleId><ArticleId IdType="pubmed">27455348</ArticleId></ArticleIdList></Reference><Reference><Citation>Le Ber I.et al. .; French Clinical and Genetic Research Network on FTLD/FTLD-ALS , TBK1 mutation frequencies in French frontotemporal dementia and amyotrophic lateral sclerosis cohorts. Neurobiol. Aging 36, 3116.e5&#x2013;3116.e8 (2015).</Citation><ArticleIdList><ArticleId IdType="pubmed">26476236</ArticleId></ArticleIdList></Reference><Reference><Citation>Li F., et al. ., Structural insights into the interaction and disease mechanism of neurodegenerative disease-associated optineurin and TBK1 proteins. Nat. Commun. 7, 12708 (2016).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5027247</ArticleId><ArticleId IdType="pubmed">27620379</ArticleId></ArticleIdList></Reference><Reference><Citation>Ye J., et al. ., Effects of ALS-associated TANK binding kinase 1 mutations on protein-protein interactions and kinase activity. Proc. Natl. Acad. Sci. U.S.A. 116, 24517&#x2013;24526 (2019).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6900539</ArticleId><ArticleId IdType="pubmed">31748271</ArticleId></ArticleIdList></Reference><Reference><Citation>de Majo M., et al. ., ALS-associated missense and nonsense TBK1 mutations can both cause loss of kinase function. Neurobiol. Aging 71, 266.e1&#x2013;266.e10 (2018).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6983933</ArticleId><ArticleId IdType="pubmed">30033073</ArticleId></ArticleIdList></Reference><Reference><Citation>Moore A. S., Holzbaur E. L. F., Dynamic recruitment and activation of ALS-associated TBK1 with its target optineurin are required for efficient mitophagy. Proc. Natl. Acad. Sci. U.S.A. 113, E3349&#x2013;E3358 (2016).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4914160</ArticleId><ArticleId IdType="pubmed">27247382</ArticleId></ArticleIdList></Reference><Reference><Citation>Gautam M., et al. ., Mitochondria, ER, and nuclear membrane defects reveal early mechanisms for upper motor neuron vulnerability with respect to TDP-43 pathology. Acta Neuropathol. 137, 47&#x2013;69 (2019).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6339587</ArticleId><ArticleId IdType="pubmed">30450515</ArticleId></ArticleIdList></Reference><Reference><Citation>Sasaki S., Horie Y., Iwata M., Mitochondrial alterations in dorsal root ganglion cells in sporadic amyotrophic lateral sclerosis. Acta Neuropathol. 114, 633&#x2013;639 (2007).</Citation><ArticleIdList><ArticleId IdType="pubmed">17929040</ArticleId></ArticleIdList></Reference><Reference><Citation>Larabi A., et al. ., Crystal structure and mechanism of activation of TANK-binding kinase 1. Cell Rep. 3, 734&#x2013;746 (2013).</Citation><ArticleIdList><ArticleId IdType="pubmed">23453971</ArticleId></ArticleIdList></Reference><Reference><Citation>Ma X., et al. ., Molecular basis of Tank-binding kinase 1 activation by transautophosphorylation. Proc. Natl. Acad. Sci. U.S.A. 109, 9378&#x2013;9383 (2012).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3386122</ArticleId><ArticleId IdType="pubmed">22619329</ArticleId></ArticleIdList></Reference><Reference><Citation>Tu D., et al. ., Structure and ubiquitination-dependent activation of TANK-binding kinase 1. Cell Rep. 3, 747&#x2013;758 (2013).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3863638</ArticleId><ArticleId IdType="pubmed">23453972</ArticleId></ArticleIdList></Reference><Reference><Citation>Goncalves A., et al. ., Functional dissection of the TBK1 molecular network. PLoS One 6, e23971 (2011).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3169550</ArticleId><ArticleId IdType="pubmed">21931631</ArticleId></ArticleIdList></Reference><Reference><Citation>Morton S., Hesson L., Peggie M., Cohen P., Enhanced binding of TBK1 by an optineurin mutant that causes a familial form of primary open angle glaucoma. FEBS Lett. 582, 997&#x2013;1002 (2008).</Citation><ArticleIdList><ArticleId IdType="pubmed">18307994</ArticleId></ArticleIdList></Reference><Reference><Citation>Richter B., et al. ., Phosphorylation of OPTN by TBK1 enhances its binding to Ub chains and promotes selective autophagy of damaged mitochondria. Proc. Natl. Acad. Sci. U.S.A. 113, 4039&#x2013;4044 (2016).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4839414</ArticleId><ArticleId IdType="pubmed">27035970</ArticleId></ArticleIdList></Reference><Reference><Citation>Jin S. M., et al. ., Mitochondrial membrane potential regulates PINK1 import and proteolytic destabilization by PARL. J. Cell Biol. 191, 933&#x2013;942 (2010).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2995166</ArticleId><ArticleId IdType="pubmed">21115803</ArticleId></ArticleIdList></Reference><Reference><Citation>Kane L. A., et al. ., PINK1 phosphorylates ubiquitin to activate Parkin E3 ubiquitin ligase activity. J. Cell Biol. 205, 143&#x2013;153 (2014).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4003245</ArticleId><ArticleId IdType="pubmed">24751536</ArticleId></ArticleIdList></Reference><Reference><Citation>Koyano F., et al. ., Ubiquitin is phosphorylated by PINK1 to activate parkin. Nature 510, 162&#x2013;166 (2014).</Citation><ArticleIdList><ArticleId IdType="pubmed">24784582</ArticleId></ArticleIdList></Reference><Reference><Citation>Ordureau A., et al. ., Dynamics of PARKIN-dependent mitochondrial ubiquitylation in induced neurons and model systems revealed by digital snapshot proteomics. Mol. Cell 70, 211&#x2013;227.e8 (2018).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5910199</ArticleId><ArticleId IdType="pubmed">29656925</ArticleId></ArticleIdList></Reference><Reference><Citation>Rose C. M., et al. ., Highly multiplexed quantitative mass spectrometry analysis of ubiquitylomes. Cell Syst. 3, 395&#x2013;403.e4 (2016).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5241079</ArticleId><ArticleId IdType="pubmed">27667366</ArticleId></ArticleIdList></Reference><Reference><Citation>Pickles S., Vigi&#xe9; P., Youle R. J., Mitophagy and quality control mechanisms in mitochondrial maintenance. Curr. Biol. 28, R170&#x2013;R185 (2018).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7255410</ArticleId><ArticleId IdType="pubmed">29462587</ArticleId></ArticleIdList></Reference><Reference><Citation>Sarraf S. A., et al. ., Landscape of the PARKIN-dependent ubiquitylome in response to mitochondrial depolarization. Nature 496, 372&#x2013;376 (2013).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3641819</ArticleId><ArticleId IdType="pubmed">23503661</ArticleId></ArticleIdList></Reference><Reference><Citation>Tanaka A., et al. ., Proteasome and p97 mediate mitophagy and degradation of mitofusins induced by Parkin. J. Cell Biol. 191, 1367&#x2013;1380 (2010).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3010068</ArticleId><ArticleId IdType="pubmed">21173115</ArticleId></ArticleIdList></Reference><Reference><Citation>Wong Y. C., Holzbaur E. L. F., Optineurin is an autophagy receptor for damaged mitochondria in parkin-mediated mitophagy that is disrupted by an ALS-linked mutation. Proc. Natl. Acad. Sci. U.S.A. 111, E4439&#x2013;E4448 (2014).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4210283</ArticleId><ArticleId IdType="pubmed">25294927</ArticleId></ArticleIdList></Reference><Reference><Citation>Heo J.-M., Ordureau A., Paulo J. A., Rinehart J., Harper J. W., The PINK1-PARKIN mitochondrial ubiquitylation pathway drives a program of OPTN/NDP52 recruitment and TBK1 activation to promote mitophagy. Mol. Cell 60, 7&#x2013;20 (2015).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4592482</ArticleId><ArticleId IdType="pubmed">26365381</ArticleId></ArticleIdList></Reference><Reference><Citation>Lazarou M., et al. ., The ubiquitin kinase PINK1 recruits autophagy receptors to induce mitophagy. Nature 524, 309&#x2013;314 (2015).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5018156</ArticleId><ArticleId IdType="pubmed">26266977</ArticleId></ArticleIdList></Reference><Reference><Citation>Evans C. S., Holzbaur E. L., Degradation of engulfed mitochondria is rate-limiting in Optineurin-mediated mitophagy in neurons. eLife 9, e50260 (2020).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6959996</ArticleId><ArticleId IdType="pubmed">31934852</ArticleId></ArticleIdList></Reference><Reference><Citation>Turco E., Fracchiolla D., Martens S., Recruitment and activation of the ULK1/Atg1 kinase complex in selective autophagy. J. Mol. Biol. 432, 123&#x2013;134 (2020).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6971721</ArticleId><ArticleId IdType="pubmed">31351898</ArticleId></ArticleIdList></Reference><Reference><Citation>Valverde D. P., et al. ., ATG2 transports lipids to promote autophagosome biogenesis. J. Cell Biol. 218, 1787&#x2013;1798 (2019).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6548141</ArticleId><ArticleId IdType="pubmed">30952800</ArticleId></ArticleIdList></Reference><Reference><Citation>Shi X., et al. ., ULK complex organization in autophagy by a C-shaped FIP200 N-terminal domain dimer. J. Cell Biol. 219, e201911047 (2020).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7337493</ArticleId><ArticleId IdType="pubmed">32516362</ArticleId></ArticleIdList></Reference><Reference><Citation>Kabeya Y., et al. ., LC3, a mammalian homologue of yeast Apg8p, is localized in autophagosome membranes after processing. EMBO J. 19, 5720&#x2013;5728 (2000).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC305793</ArticleId><ArticleId IdType="pubmed">11060023</ArticleId></ArticleIdList></Reference><Reference><Citation>Wild P., et al. ., Phosphorylation of the autophagy receptor optineurin restricts Salmonella growth. Science 333, 228&#x2013;233 (2011).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3714538</ArticleId><ArticleId IdType="pubmed">21617041</ArticleId></ArticleIdList></Reference><Reference><Citation>Padman B. S., et al. ., LC3/GABARAPs drive ubiquitin-independent recruitment of Optineurin and NDP52 to amplify mitophagy. Nat. Commun. 10, 408 (2019).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6345886</ArticleId><ArticleId IdType="pubmed">30679426</ArticleId></ArticleIdList></Reference><Reference><Citation>Wilson R. J., et al. ., Conditional MitoTimer reporter mice for assessment of mitochondrial structure, oxidative stress, and mitophagy. Mitochondrion 44, 20&#x2013;26 (2019).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6387589</ArticleId><ArticleId IdType="pubmed">29274400</ArticleId></ArticleIdList></Reference><Reference><Citation>Narendra D., Tanaka A., Suen D. F., Youle R. J., Parkin is recruited selectively to impaired mitochondria and promotes their autophagy. J. Cell Biol. 183, 795&#x2013;803 (2008).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2592826</ArticleId><ArticleId IdType="pubmed">19029340</ArticleId></ArticleIdList></Reference><Reference><Citation>Ordureau A., et al. ., Quantitative proteomics reveal a feedforward mechanism for mitochondrial PARKIN translocation and ubiquitin chain synthesis. Mol. Cell 56, 360&#x2013;375 (2014).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4254048</ArticleId><ArticleId IdType="pubmed">25284222</ArticleId></ArticleIdList></Reference><Reference><Citation>Martin K. R., et al. ., A potent and selective ULK1 inhibitor suppresses autophagy and sensitizes cancer cells to nutrient stress. iScience 8, 74&#x2013;84 (2018).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6172447</ArticleId><ArticleId IdType="pubmed">30292171</ArticleId></ArticleIdList></Reference><Reference><Citation>Tanida I., Ueno T., Kominami E., LC3 conjugation system in mammalian autophagy. Int. J. Biochem. Cell Biol. 36, 2503&#x2013;2518 (2004).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7129593</ArticleId><ArticleId IdType="pubmed">15325588</ArticleId></ArticleIdList></Reference><Reference><Citation>Heo J. M., et al. ., RAB7A phosphorylation by TBK1 promotes mitophagy via the PINK-PARKIN pathway. Sci. Adv. 4, eaav0443 (2018).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6314648</ArticleId><ArticleId IdType="pubmed">30627666</ArticleId></ArticleIdList></Reference><Reference><Citation>Vargas J. N. S., et al. ., Spatiotemporal control of ULK1 activation by NDP52 and TBK1 during selective autophagy. Mol. Cell 74, 347&#x2013;362.e6 (2019).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6642318</ArticleId><ArticleId IdType="pubmed">30853401</ArticleId></ArticleIdList></Reference><Reference><Citation>Herhaus L., et al. ., TBK1-mediated phosphorylation of LC3C and GABARAP-L2 controls autophagosome shedding by ATG4 protease. EMBO Rep. 21, e48317 (2020).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6945063</ArticleId><ArticleId IdType="pubmed">31709703</ArticleId></ArticleIdList></Reference><Reference><Citation>Pomerantz J. L., Baltimore D., NF-kappaB activation by a signaling complex containing TRAF2, TANK and TBK1, a novel IKK-related kinase. EMBO J. 18, 6694&#x2013;6704 (1999).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC1171732</ArticleId><ArticleId IdType="pubmed">10581243</ArticleId></ArticleIdList></Reference><Reference><Citation>Mitchell J. D., Borasio G. D., Amyotrophic lateral sclerosis. Lancet 369, 2031&#x2013;2041 (2007).</Citation><ArticleIdList><ArticleId IdType="pubmed">17574095</ArticleId></ArticleIdList></Reference><Reference><Citation>He L., Chen L., Li L., The TBK1-OPTN Axis mediates crosstalk between mitophagy and the innate immune response: A potential therapeutic target for neurodegenerative diseases. Neurosci. Bull. 33, 354&#x2013;356 (2017).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5567518</ArticleId><ArticleId IdType="pubmed">28271436</ArticleId></ArticleIdList></Reference><Reference><Citation>Sarraf S. A., et al. ., PINK1/Parkin influences cell cycle by sequestering TBK1 at damaged mitochondria, inhibiting mitosis. Cell Rep. 29, 225&#x2013;235.e5 (2019).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6880866</ArticleId><ArticleId IdType="pubmed">31577952</ArticleId></ArticleIdList></Reference><Reference><Citation>Onorati M., et al. ., Zika virus disrupts phospho-TBK1 localization and mitosis in human neuroepithelial stem cells and radial glia. Cell Rep. 16, 2576&#x2013;2592 (2016).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5135012</ArticleId><ArticleId IdType="pubmed">27568284</ArticleId></ArticleIdList></Reference><Reference><Citation>Gkikas I., Palikaras K., Nektarios tavernarakis, the role of mitophagy in innate immunity. Front. Immunol. 9, 1&#x2013;15 (2018).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6008576</ArticleId><ArticleId IdType="pubmed">29951054</ArticleId></ArticleIdList></Reference><Reference><Citation>Oka T., et al. ., Mitochondrial DNA that escapes from autophagy causes inflammation and heart failure. Nature 485, 251&#x2013;255 (2012).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3378041</ArticleId><ArticleId IdType="pubmed">22535248</ArticleId></ArticleIdList></Reference><Reference><Citation>Fang E. F., et al. ., Mitophagy inhibits amyloid-&#x3b2; and tau pathology and reverses cognitive deficits in models of Alzheimer&#x2019;s disease. Nat. Neurosci. 22, 401&#x2013;412 (2019).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6693625</ArticleId><ArticleId IdType="pubmed">30742114</ArticleId></ArticleIdList></Reference><Reference><Citation>van Horssen J., van Schaik P., Witte M., Inflammation and mitochondrial dysfunction: A vicious circle in neurodegenerative disorders? Neurosci. Lett. 710, 132931 (2017).</Citation><ArticleIdList><ArticleId IdType="pubmed">28668382</ArticleId></ArticleIdList></Reference><Reference><Citation>Gerbino V., et al. ., The loss of TBK1 kinase activity in motor neurons or in all cell types differentially impacts ALS disease progression in SOD1 mice. Neuron 106, 789&#x2013;805.e5 (2020).</Citation><ArticleIdList><ArticleId IdType="pubmed">32220666</ArticleId></ArticleIdList></Reference><Reference><Citation>Brenner D., et al. ., Heterozygous Tbk1 loss has opposing effects in early and late stages of ALS in mice. J. Exp. Med. 216, 267&#x2013;278 (2019).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6363427</ArticleId><ArticleId IdType="pubmed">30635357</ArticleId></ArticleIdList></Reference><Reference><Citation>Schindelin J., et al. ., Fiji: An open-source platform for biological-image analysis. Nat. Methods 9, 676&#x2013;682 (2012).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3855844</ArticleId><ArticleId IdType="pubmed">22743772</ArticleId></ArticleIdList></Reference><Reference><Citation>Berg S., et al. ., ilastik: Interactive machine learning for (bio)image analysis. Nat. Methods 16, 1226&#x2013;1232 (2019).</Citation><ArticleIdList><ArticleId IdType="pubmed">31570887</ArticleId></ArticleIdList></Reference><Reference><Citation>McQuin C., et al. ., CellProfiler 3.0: Next-generation image processing for biology. PLoS Biol. 16, e2005970 (2018).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6029841</ArticleId><ArticleId IdType="pubmed">29969450</ArticleId></ArticleIdList></Reference><Reference><Citation>Harding O., et al. ., ALS and FTD-associated missense mutations in TBK1 differentially disrupt mitophagy. Zenodo. 10.5281/zenodo.4670341. Deposited 9 April 2021.</Citation><ArticleIdList><ArticleId IdType="doi">10.5281/zenodo.4670341</ArticleId><ArticleId IdType="pmc">PMC8214690</ArticleId><ArticleId IdType="pubmed">34099552</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>